" For more than 20 years , FDA has been asking manufacturers to conduct and report rigorous studies on the safety and effectiveness of breast implants . This committee is now very aware of the limitations of the current post approval studies . This leaves us in much the same place as in 2007 , or indeed as in 1992 , " Wood said . " FDA approved these products by two companies contingent on adequate post approval studies . These studies do not seem to reach the bar . "
